Product NDC: | 55111-646 |
Proprietary Name: | Letrozole |
Non Proprietary Name: | Letrozole |
Active Ingredient(s): | 2.5 mg/1 & nbsp; Letrozole |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55111-646 |
Labeler Name: | Dr. Reddy's Laboratories Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA091191 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110603 |
Package NDC: | 55111-646-78 |
Package Description: | 10 BLISTER PACK in 1 CARTON (55111-646-78) > 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-646-79) |
NDC Code | 55111-646-78 |
Proprietary Name | Letrozole |
Package Description | 10 BLISTER PACK in 1 CARTON (55111-646-78) > 10 TABLET, FILM COATED in 1 BLISTER PACK (55111-646-79) |
Product NDC | 55111-646 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Letrozole |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110603 |
Marketing Category Name | ANDA |
Labeler Name | Dr. Reddy's Laboratories Limited |
Substance Name | LETROZOLE |
Strength Number | 2.5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aromatase Inhibitor [EPC],Aromatase Inhibitors [MoA] |